BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25024090)

  • 1. Role of chemoradiotherapy in the adjuvant and neoadjuvant settings for resectable pancreatic cancer.
    Sen N; Falk S; Abrams RA
    Clin Oncol (R Coll Radiol); 2014 Sep; 26(9):551-9. PubMed ID: 25024090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of radiation therapy in patients with resectable pancreatic cancer.
    Palta M; Willett C; Czito B
    Oncology (Williston Park); 2011 Jul; 25(8):715-21, 727. PubMed ID: 21874833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of radiation therapy in pancreatic ductal adenocarcinoma in the neoadjuvant and adjuvant settings.
    Franke AJ; Rosati LM; Pawlik TM; Kumar R; Herman JM
    Semin Oncol; 2015 Feb; 42(1):144-62. PubMed ID: 25726059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant vs adjuvant therapy for resectable pancreatic cancer: the evolving role of radiation.
    Hoffe S; Rao N; Shridhar R
    Semin Radiat Oncol; 2014 Apr; 24(2):113-25. PubMed ID: 24635868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings.
    Badiyan SN; Molitoris JK; Chuong MD; Regine WF; Kaiser A
    Surg Oncol Clin N Am; 2017 Jul; 26(3):431-453. PubMed ID: 28576181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma in 2006].
    Deberne M; Huguet F; Le Scodan R; Hammel P; Andre T
    Bull Cancer; 2007 Jan; 94(1):72-80. PubMed ID: 17237007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for chemoradiotherapy in the treatment of pancreatic carcinoma?
    Pasetto LM; Jirillo A; Stefani M; Monfardini S
    Anticancer Res; 2003; 23(3C):2805-13. PubMed ID: 12926117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pancreatic carcinoma. Optimizing therapy by adjuvant and neoadjuvant therapy?].
    Maurer CA; Zgraggen K; Büchler MW
    Zentralbl Chir; 1999; 124(5):401-7. PubMed ID: 10420525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies.
    Kleeff J; Michalski CW; Friess H; Büchler MW
    Eur J Surg Oncol; 2007 Sep; 33(7):817-23. PubMed ID: 17331695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving concepts regarding the use of radiotherapy in the adjuvant management of periampullary pancreatic adenocarcinoma.
    Abrams RA
    Cancer J; 2012; 18(6):624-32. PubMed ID: 23187851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in the management of borderline resectable pancreatic cancers.
    Goodman MD; McPartland S; Huber K; Saif MW
    JOP; 2013 Jul; 14(4):334-6. PubMed ID: 23846921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
    Stessin AM; Meyer JE; Sherr DL
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant/neoadjuvant chemoradiation for gastric and pancreatic cancer.
    Lowy AM; Leach SD
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):121-30. PubMed ID: 10550836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative adjuvant therapy for pancreatic cancer.
    Penberthy DR; Rich TA; Adams RB
    Semin Surg Oncol; 2003; 21(4):256-60. PubMed ID: 14648783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical overview: adjuvant therapy of gastrointestinal cancer.
    Macdonald JS
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S4-11. PubMed ID: 15309508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiochemotherapy in the management of pancreatic cancer--part I: neoadjuvant treatment.
    Mornex F; Girard N; Delpero JR; Partensky C
    Semin Radiat Oncol; 2005 Oct; 15(4):226-34. PubMed ID: 16183476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer].
    Scheufele F; Friess H
    Chirurg; 2020 May; 91(5):391-395. PubMed ID: 31965198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.
    Sperti C; Pasquali C; Pastorelli D; Ferronato A; Decet G; Pedrazzoli S
    Acta Biomed; 2003; 74 Suppl 2():91-5. PubMed ID: 15055044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.